Inventor
HON-WAH MAN
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07BGeneral methods of organic chemistry21%
C07CAcyclic or carbocyclic compounds8%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
12,391,672Solid forms comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same202512,029,738Antiproliferative compounds and methods of use thereof202411,780,801Methods of synthesis of (1R,2R,5R)-5-amino-2-methyl-cyclohexanol hydrochloride and intermediates useful therein202311,655,257MK2 inhibitors, synthesis thereof, and intermediates thereto202311,492,332Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide202211,414,399Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same202211,370,777Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same202211,260,046(+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof202211,241,423Antiproliferative compounds and methods of use thereof202211,241,430Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use202211,192,847Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein202111,185,543Antiproliferative compounds and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CELGENE CORP (8)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to SIGNAL PHARM LLC (2)· patent assignee history
2022Patents assigned to AMGEN INC (1)· patent assignee history
2023Patents assigned to CELGENE CAR LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 8 | 2021–2025 |
| SIGNAL PHARM LLC | 2 | 2022 |
| AMGEN INC | 1 | 2022 |
| CELGENE CAR LLC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2021–2025 |